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1. Introduction 
Spinal cord injury is one of the most serious conditions in the field of orthopedic surgery. 
Several pharmacological trials have been performed for the treatment of traumatic spinal 
cord injury. However, only high-dose steroid therapy has been established as an effective 
treatment for this condition. It is necessary to develop an effective treatment to inhibit 
secondary neuronal damage and to promote neuronal regeneration after the spinal cord 
injury. 
Recently, direct delivery of neurotrophic factors, such as nerve growth factor (NGF), glial-
derived neurotrophic factor (GDNF), and brain-derived neurotrophic factor (BDNF), has 
been demonstrated to provide neuroprotection and counteract lesion-induced atrophy after 
traumatic injury to the central nervous system (CNS) (Kobayashi et al., 1997; Houle et al., 
1999; Bregman et al., 2002; Cao et al., 2002; Zhou, et al., 2006).  
Intravenous applications of neurotrophic factors, such as GDNF and BDNF, are also 
possible therapeutic methods. In the injured spinal cord, however, blood flow in the 
nervous tissue decreases remarkably (Hamamoto et al., 2007). When neuroprotective 
substances are added intravenously, only a small amount of the substances reach the injured 
portion of the spinal cord. In addition, the half lives of most proteins in vivo are relatively 
short. Therefore, systemic intravenous administration of neurotrophic protein may not be an 
efficient way to treat damaged spinal cord tissue. 
Direct infusion of neurotrophic proteins into the neural parenchyma using pumps is 
another approach to treatment. However, several limitations should be considered as 
follows: 1) The spread of the proteins throughout the neural parenchyma is often limited. 






neural scar at the insertion site. 3) The implanted canula may induce inflammation or 
clogging of the infusion device. 4) Continuous outflow of liquid can cause additional 
damage at the insertion site. 
Several trials of gene transfer into the CNS have been conducted both in vivo and in vitro. 
Adenovirus including the target genes has been successfully used to achieve gene transfer in 
the CNS (Fink et al., 2000; Miagkov et al., 2004; Kwon et al., 2007). However, viral infection 
of the CNS may be too dangerous for clinical use because of the risk of meningitis (Driesse 
et al., 2000).  
To develop a novel system for substance delivery to damaged ischemic tissue, we focused 
on the tissue-migration ability of macrophages. Macrophages migrate into damaged tissue 
or inflammatory tissue. After spinal cord injury, the appearance of macrophages in the 
damaged tissue has been reported (Dusart et al., 1994; Morino et al., 2003). For this study, 
gene transfer by ex vivo electroporation, a non-viral gene transfer method, was performed 
on autologous macrophages, and the cells were injected into the subarachnoid space. It is 
believed that if the cells migrate and concentrate in the damaged spinal cord, it will 
provide a safe and effective method of substance delivery to the damaged spinal cord 
parenchyma. 
2. Experimental procedures 
2.1 Animals 
A total of 56 male Wistar rats (350 g-weight, purchased from Japan Clea Co., Japan) were 
used for this experiment (in vivo 50, in vitro 6). The research protocol was accepted by the 
ethical committee for animal experiments at Ehime University (Ehime, Japan). 
2.2 Collection of autologous macrophages and GFP gene incorporation 
Intraperitoneal macrophages were easily collected from rats. The intraperitoneal space was 
rinsed with 30 ml of Dulbecco's modified Eagle medium (DMEM, Gibco, Grand Island, NY) 
via midline incision of the abdomen. The DMEM, which contained a large concentration of 
macrophages, was collected and centrifuged, and cells were re-suspended in cell 
permeabilization buffer (140 mM KCl, 5 mM NaCl, 10 mM glucose, 0.5 mM EGTA, 10 mM 
HEPES, pH 7.2). To identify gene-transfected cells, we used pEGFPLuc Vector (Clontech Inc. 
USA). This vector was constructed by inserting the GFP gene for over-expression of GFP 
protein. 200 l of the cells (1 x 106 cells /ml) were mixed with 20 l of GFP-containing vector 
in disposable cuvette-electrodes (2 mm gap, BTZ 620, BTX Inc., USA). The final 
concentration of the vector was 0.1 g/l. Then, six 20 ms electric pulses of 20 V were 
applied by electroporator (CUY 21, NEPA GENE Co., Japan). The treated cells were then 
cultured (in vitro) or returned to the animals by intrathecal application (in vivo). 
2.3 Cell culturing and observation of GFP protein expression 
The gene-transfected macrophages were cultured in 6-well culture plates (Nunc, Naperville, 
IL) at a concentration of 5 x 104 cells/well with DMEM containing 15% fetal calf serum. 
Culturing was performed in a humidified 5% CO2 atmosphere at 37°C. Seven days after 
culturing, the cells were observed under a fluorescent microscope. 
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2.4 Spinal cord injury model (SCI model) 
Under general anesthesia using halothane, the rat spinal cord was carefully exposed by 
removing the vertebral lamina at the 11th vertebra. Spinal cord impact injury was 
performed using a MASCIS Impactor (New Jersey, USA). The impact weight was dropped 
from a height of 25 mm. In one group of rats, a laminectomy of the 11th vertebra was 
performed without spinal cord injury (sham). 
2.5 Macrophage transplantation into the spinal cord by lumbar puncture 
100 l of a liquid suspension of the gene-transfected macrophages (1 x 105 cells) was injected 
into the subarachnoid space at the 4-5th lumbar intervertebral level just after the spinal cord 
injury.  
2.6 Histological examination 
Rats were sacrificed for histological study by deep anesthesia using diethyl ether and their 
spinal cords were taken out immediately. Horizontal or axial frozen sections with a 
thickness of 20 m were produced, and autofluorescence was observed under fluorescence 
microscopy. To quantify the number of migrated gene-transfected macrophages, 
photographs at an area peripheral to the center of the SCI were taken and the number of 
GFP-positive cells were counted by three individuals who did not know any information 
about the pictures. For the first 96 hours after the SCI, the GFP autofluorescence was weak, 
and therefore, the cells were hardly distinguishable from the background until after 96 
hours had elapsed. The counts were averaged and data were expressed as the number of 
GFP-positive cells per 1 mm2. 
To confirm the expression of transferred GFP, some sections were subjected to 
immunostaining by anti-GFP antibody according to avidin-biotin-complex (ABC) method 
using Vectastain ABC kit (Vector labo. Inc., CA). The sections were fixed on glass slides 
with 4% paraformaldehyde in phosphate-buffered saline (PBS) for 5 minutes. Then, after 
washing twice with PBS, endogenous peroxidase was blocked by treatment with 3% 
H2O2/H2O for 5 minutes. Slices were exposed to anti-GFP antibody (1:1000 in 1% horse 
serum/PBS; MBL Co., Ltd., Nagoya, Japan) overnight at 4C. Sections were then washed 
by PBS and exposed to biotin-conjugated anti-rabbit IgG for 1 hour at room temperature. 
After washing the antibody, sections were treated by ABC method according to the assay 
protocol of the kit, and finally colour developed with 3,3'-diaminobenzidine 
tetrahydrochloride (DAB, Wako Chemicals Ltd.) substrate (0.02% H2O2 plus 0.1% DAB in 
0.1M Tris-buffer) for 5 minutes and washed immediately with water for 20 minutes. 
Sections were dehydrated through graded alcohols and xylene and were then mounted in 
HSR solution (Yoshitomi co., Osaka, Japan). 
To clarify which kinds of cells had been transplanted, some sections were subjected to 
immunostaining by OX-42, a marker of macrophages. Frozen sections were prepared 
according to the method mentioned above. Then, after washing twice with PBS, slices on 
slides were exposed to anti-OX42 antibody (Immunotech. Co. Marseille, France) overnight 
at 4C, and rhodamine-conjugated anti-mouse IgG antibody (Chemicon International Co. 






2.7 Evaluation of motor function 
Motor function was assessed with the Basso, Beattie and Bresnahan (BBB) scoring scale 
(Basso et al., 1996). The BBB scale is a 21-point scale that ranks no locomotion as 0 points and 
a normal gait as 21 points. The BBB scale is one of the most widely used methods for 
evaluating hind-limb motor function in rats and mice. Hind-limb motor function was 
evaluated at 2, 3, 4, 7, 14, 21, 28, and 56 days after SCI. The evaluation of  BBB scores was 
done by three individuals who were unaware of the treatments that the rats had received. 
The average of the three observers’ scores was employed as data in this study. 
3. Results 
3.1 Expression of green fluorescent protein (GFP) protein in cultured gene-
transfected macrophages 
The cultured cells were observed under fluorescent microscopy. Detectable autofluorescence 
was observed from the 3rd day of the culture, and the intensity of the autofluorescence 
increased with time. Fig 1 shows an example of typical autofluorescence at 7 days after 
culturing. We were able to maintain cells with autofluorescence in a culture dish for 2 
weeks.  
 
Fig. 1. Photographs of typical GFP autofluorescence in cultured macrophages 7 days after 
culturing. 
Intra-peritoneal macrophages were harvested from a rat. Then vectors containing GFP were 
transferred by ex vivo electroporation. 
3.2 Hind-limb motor function after spinal cord injuries (SCI) 
In sham animals, those without an impact injury, no symptoms were observed in the lower 
limbs (21 points). In the rats with spinal cord injuries (SCI), almost complete paresis of the 
hind limbs was observed just after the injury (0 points). Motor function recovery started 7 
days after the injury, and the recovery reached a plateau at 4 weeks after the injury (13.7 ± 
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0.94 points). The paresis did not recover until 8 weeks after the injury (Fig. 2). BBB scores in 
the sham animals were consistently 21 points. 
 
Fig. 2. Time course of hind-limb motor function after spinal cord injury evaluated by the 
BBB scale. 
Spinal cord impact injury was performed using a MASCIS impactor. The impact weight was 
dropped from a height of 25 mm. Hind-limb motor function was evaluated using the BBB 
scale. Data are mean ± SEM (n = 4 to 6). 
3.3 Histological results  
In slices obtained from SCI rats three or four days after the injury, weak autofluorescence 
was detected in the center of the compressed part and on the surface of the spinal cord (data 
not shown). One week after the injury, the fluorescence was strong enough to easily 
differentiate between fluorescent and non-fluorescent cells. From this point, we were able to 
count the number of GFP-positive cells in the slices.  
Injected macrophages migrated and concentrated in the injured part of the spinal cord. Most 
of the GFP-positive cells were detected in the gray matter, especially in the area peripheral 
to the cavity caused by necrotic cell death (Fig. 3A). There were few GFP-positive cells in the 
white matter or the pia mater (Fig. 3B). There were few GFP-positive cells in the areas 1-cm 
rostral or caudal to the center of impact (data not shown). In summary, most of the GFP-
positive cells appeared in the injured area in spite of the fact that the cells were injected 
intrathecally. This result indicates that the injected autologous macrophages migrated and 
concentrated in the gray matter of the injured spinal cord. 
Fluorescence intensity and the number of GFP-positive cells increased with time and peaked 






countable GFP-positive cells. The number of GFP-positive cells peaked at three weeks after 
the SCI (32.0 ± 10.3 cells / mm2 in 20 m slice). Autofluorescence was detected even 2 
months after the injury/injection. The gene-transfected macrophages successfully stayed in 
the injured area and survived for a long period of time. 
In order to confirm that autofluorescence was detected only from GFP gene-transfected 
macrophages, we performed anti-GFP staining (Fig. 6) and OX-42 staining (Fig. 7) in slices 
obtained two weeks after the injury.  
Figure 6 shows anti-GFP staining of the thoracic spinal cord. The cells, which were positive 
to anti-GFP antibody, were observed in the thoracic spinal cord tissue in the area peripheral 
to the cavity caused by necrotic cell death. 
OX-42 staining (Fig. 7) showed that most of the OX-42-positive macrophages revealed GFP 
autofluorescence. There were a few OX-42-positive cells which did not show 
autofluorescence. These cells might be microglia which appeared after the injury. All of the 
GFP-positive cells were also positive for OX-42.  
 
 
Fig. 3. Distribution of GFP-positive macrophages in the spinal cord four weeks after 
transplantation.  
GFP-gene transfected autologous macrophages were injected by lumbar puncture after the 
spinal cord injury. Four weeks after the injection, a sample of the injured spinal cord was 
www.intechopen.com
Autologous Macrophages Genetically Modified  
by Ex Vivo Electroporation and Inserted by Lumbar Puncture Migrate...  
 
143 
taken and axial sections were subjected to histological examination. Most of the GFP-
positive cells were detected in the gray matter (A). There were few GFP-positive cells in the 
white matter or in the pia mater (B). 
 
Fig. 4. Autofluorescence of GFP-positive macrophages in the gray matter of the injured 
spinal cord. GFP-gene transfected autologous macrophages were injected by lumbar 
puncture after the spinal cord injury. One (A), two (B), three (C) and four (D) weeks after the 
injury/injection, a sample of the injured spinal cord was taken and horizontal sections were 
subjected to histological examination. The pictures show the areas peripheral to the center of 
the impact injury. 
 
Fig. 5. Number of GFP-positive cells in the center of the damaged spinal cord tissue.  
At the indicated time point after the injury/injection, a sample of the injured spinal cord 






which revealed significant autofluorescence in the area peripheral to the center of impact 
injury, were counted. Data are shown in mean ± SEM (n = 4 to 6). 
 
Fig. 6. Anti-GFP staining of the spinal cord two weeks after transplantation.  
Two weeks after the injection, a sample of the injured spinal cord was taken and horizontal 
sections were subjected to histological examination. Horizontal sections in the thoracic 
spinal cord were stained by anti-GFP antibody. Gene-transferred autologous macrophages 
migrated into the spinal cord tissue (arrows).  
 
Fig. 7. Co-localization of OX-42 and GFP protein in the cells in the injured portion of spinal 
cord. 
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Two weeks after the injection, a sample of the injured spinal cord was taken and horizontal 
sections were subjected to histological examination. A: autofluorescence of GFP-positive 
cells, B: OX-42 immunoreactive cells, C: Overlap photograph of GFP autofluorescence and 
OX-42. Most of the OX-42-positive macrophages showed GFP autofluorescence. 
4. Discussion 
Gene transfer to injured spinal cord tissue is thought to be an effective method for the 
treatment of spinal cord injury. For example, over-expression of neurotrophic factors, such 
as NGF or BDNF, may be an effective method of promoting the recovery of motor function, 
and over-expression of endogenous opioids, such as endorphin or enkephalin, may be 
effective for the reduction of hyperalgesia or spontaneous pain after spinal cord injury.  
Electroporation has been used for several types of gene transfer, such as muscle (Watanabe 
et al., 2001), skin (Maruyama et al., 2001), tumor (Yamashita et al., 2001), and spinal cord 
gene transfer (Lin et al., 2002). To establish a method of transferring the gene into 
macrophages, we tested electroporation under several different conditions. Technical 
procedures for electroporation have been reported, but considerable variation in the ideal 
intensity of electric stimulation has been described in the literature. Since no report 
describing a method of electroporation for macrophages was available, we have tested 
several conditions to determine a proper method to treat macrophages. In particular, the 
stimulation voltage and duration were very important. When we applied six 20 ms pulses of 
20 V to the cuvette-electrode with a 2 mm gap, the total current was between 1.1 and 1.4 A. 
More than 80% of the surviving macrophages showed autofluorescence in the culture plate 
(data not shown). When we applied a voltage higher than 50V or applied a pulse for a 
duration longer than 50 ms, most of the cells died within 48 hours. When we applied six 20 
ms pulse of 10 V, the cells survived, but no detectable autofluorescence was seen within 1 
week. Therefore, we think the conditions we used in this study are ideal for macrophage 
electroporation. 
Direct implantation of several kinds of cells into the damaged spinal cord has been reported. 
These reports show that implantation of several kinds of cells into the damaged nervous 
tissue may promote neuronal regeneration. The candidates for donor cells for spinal cord 
injuries are bone marrow stromal cells (Kamada et al., 2005), macrophages (Rapalino et al., 
1998; Schwartz et al., 1999) and neural stem cells (Iwanami et al., 2005). However, direct 
injection of the cells into the spinal cord may be a dangerous procedure for clinical use. 
Recently, more less-invasive transplantation procedures have been reported. Bakshi et 
al.(2004, 2006) reported that bone marrow stem cells and neural precursor cells migrated 
into the damaged spinal cord tissue via intrathecal injection. Lepore et al. (2005) also 
reported that neural stem cells migrated into the damaged spinal cord tissue via intrathecal 
injection. They also tested the intravenous injection of neural stem cells. Some stem cells 
reached the damaged spinal cord tissue, although not as many as in the intrathecal injection 
procedure. In our result, the intrathecally injected autologous macrophage appeared around 
the center of damaged spinal cord tissue. There were few migrated macrophage in the areas 
1-cm rostral or caudal to the center of impact. These results suggest that the cells, which 
have migration activity similar to immature stem cells, are led to the damaged tissue. 
Macrophages, immune cells which are distributed widely in the body, have strong 






cells per 1 liter of blood. When inflammation occurs, they migrate into the damaged tissue 
and change into macrophages. Macrophages are available in injured nervous tissue after 
spinal cord or peripheral nerve injuries (Leskovar et al., 2000; Morino et al., 2003). 
Inflammation after an injury may be an inducer of monocyte/macrophage migration. The 
hypothesis of this study was that if autologous macrophages exist in the subarachnoid space 
after a spinal cord injury, they may migrate and concentrate in the center of the inflamed or 
damaged area. This hypothesis has proven to be correct. In the present study, macrophages 
were collected from rats, and plasmids including the target gene were transferred into the 
cells by ex vivo electroporation. Then, the gene-transfected autologous macrophages were 
returned to the subarachnoid space. We successfully implanted the gene-transfected 
autologous macrophages into the injured part of the spinal cord by intrathecal injection. 
This method is much safer than direct injection of the cells into the injured area. 
Neuroprotective therapies using neurotrophic factors may be effective not only for acute 
spinal cord injuries, but also for chronic stages after the injury. Kwon et al. (2002) reported 
that rubrospinal neurons, whose axons had been cut in the cervical spinal cord 1 year before, 
have regenerative capacity and that massive atrophy of rubrospinal neurons can be reversed 
by applying BDNF. 
Therefore, we should develop therapeutic methods for the treatment of both the acute and 
chronic phase of the neurodegenerative and regenerative processes. For the treatment of the 
acute phase of spinal cord injury, we previously reported that hypothermic treatment 
(Ogata et al., 2000) and intrathecal application of SB203580, a selective inhibitor of p38 
mitogen-activated protein kinase (Horiuchi et al., 2003) effectively induced motor function 
recovery after SCI. For treatment of more chronic stages of SCI, continuous delivery of 
neuroprotective or neuroregenerative substances, such as neurotrophic proteins, should be 
required for at least several months. In the present study, we demonstrated that implanted 
autologous macrophages survived for a long period of time (more than 2 months) and GFP 
expression continued from one week to 2 months after the injection (Fig. 5). If this procedure 
of gene transfer by a single injection is performed every two months, substance delivery can 
be achieved continuously for one year or more. 
Since an enormous amount of intra-peritoneal macrophages can be easily collected from rats 
or mice, we used intra-peritoneal macrophages in the present study. If this procedure is 
used in humans, monocytes, the precursor cells of macrophages, could be collected from 
peripheral blood and used instead of macrophages. Since a considerable amount of 
monocytes can be easily collected from peripheral blood, repetitive cell transplantation via 
lumbar puncture may be carried out easily. 
In summary, we successfully transferred the GFP gene into the damaged spinal cord via 
gene-transfected autologous macrophages by intrathecal injection. This method may be a 
useful substance-delivery system for the treatment of spinal cord injury. 
5. Conclusion 
In the present study, we successfully transferred the GFP gene into the damaged spinal cord 
via gene-transfected autologous macrophages by intrathecal injection. This method may be a 
useful substance-delivery system for the treatment of spinal cord injury. 
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